ESAB Corporation announced its second quarter 2025 financial results, reporting sales of $716 million, a 1% increase on a reported basis but a 1% decrease in core organic growth year-over-year. The company achieved net income from continuing operations of $69 million, with diluted earnings per share of $1.12. Core adjusted net income was $84 million, leading to $1.36 in core adjusted diluted earnings per share.
The company delivered record core adjusted EBITDA margins, expanding by 30 basis points to 20.4%, with core adjusted EBITDA reaching $138 million, a 3% increase. This performance was driven by robust demand in the EMEA and APAC segments, which saw core sales climb 11.0%, offsetting organic sales declines in the Americas.
ESAB advanced its compounder strategy by completing two strategic acquisitions: DeltaP and Aktiv, which expand its medical gas control business. The company also signed an agreement to acquire EWM, a European leader in heavy industrial and robotic welding equipment, further enhancing its Fabtech portfolio.
ESAB raised its full-year 2025 outlook for total core sales growth to 1.5% to 3.5% from the prior (1.0)% to 1.5%. The core adjusted EBITDA outlook was increased to $525 million to $535 million, up from $520 million to $530 million. Core adjusted EPS guidance was also raised to $5.15 to $5.30 from $5.10 to $5.25.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.